Press release
Plaque Psoriasis (Psoriasis Vulgaris) Clinical Market Strengthens as Biologics, Targeted Therapies & Digital Dermatology Transform Patient Care
Plaque Psoriasis (Psoriasis Vulgaris) Clinical Market
Download Full PDF Sample Copy of Market Report @https://exactitudeconsultancy.com/request-sample/73631
Market Overview
The Global Plaque Psoriasis (Psoriasis Vulgaris) Clinical Market is projected to grow at a healthy CAGR of 6.8% from 2023 to 2030, driven by:
• Increasing prevalence of immune-mediated inflammatory diseases
• Rising usage of biologics and targeted synthetic therapies (tsDMARDs)
• Advancements in digital diagnostics & tele-dermatology
• Growing awareness and early treatment adoption
• Expansion of clinical trials exploring next-gen dermatology drugs
Plaque psoriasis represents ~80-90% of psoriasis cases and is characterized by red, scaly skin plaques resulting from hyper-proliferation of keratinocytes driven by immune dysregulation.
Key Takeaways
• Demand is rising for IL-17, IL-23, TNF-α inhibitors, and JAK-targeted therapies.
• Topical treatments remain foundational, especially for mild to moderate plaque psoriasis.
• Combination therapy strategies are increasingly used for difficult-to-treat patients.
• Digital dermatology and AI-powered skin assessment tools are enhancing diagnosis and monitoring.
Market Story - Why Psoriasis Clinical Management Is Rapidly Evolving
Plaque psoriasis is a lifelong condition requiring tailored, continuous management. Its systemic inflammatory nature is linked to comorbidities such as psoriatic arthritis, cardiovascular disease, obesity, and metabolic syndrome-driving the need for comprehensive clinical care.
Innovations in psoriasis therapeutics include:
• Highly selective biologics offering rapid and sustained skin clearance
• JAK inhibitors & small molecules enhancing oral treatment options
• Non-steroidal topical therapies with improved safety profiles
• Phototherapy advancements including targeted UVB and home-based devices
• AI-assisted diagnostic apps improving patient engagement
These advancements significantly improve quality of life, treatment adherence, and long-term disease control.
Market Segmentation
By Disease Severity
• Mild Plaque Psoriasis
• Moderate Plaque Psoriasis
• Severe Plaque Psoriasis
By Diagnosis Method
• Physical Clinical Examination
• Dermoscopy
• Skin Biopsy
• PASI Scoring Systems
• AI-Enhanced Dermatology Tools
By Treatment Type
Topical Therapies
• Corticosteroids
• Vitamin D Analogues
• Calcineurin Inhibitors
• Topical Retinoids
• Combination Topicals
Systemic Therapies
• Methotrexate
• Cyclosporine
• Acitretin
Targeted Therapies
• IL-17 Inhibitors
• IL-23 Inhibitors
• TNF-α Inhibitors
• PDE-4 Inhibitors
• JAK Inhibitors
• Emerging Biologic Agents
Other Treatments
• Phototherapy (NB-UVB, PUVA)
• Home-based Light Therapy
• Lifestyle & Behavioral Interventions
By End User
• Dermatology Clinics
• Hospitals
• Specialty Skin Care Centers
• Tele-Dermatology & Digital Health Platforms
• Research Institutions
By Region
• North America - High biologics adoption & strong dermatology expertise
• Europe - Favorable reimbursement for biologics and advanced therapies
• Asia Pacific - Fastest-growing due to rising awareness and expanding healthcare access
• Latin America - Increasing clinical diagnosis & topical therapy adoption
• Middle East & Africa - Growing investment in dermatology infrastructure
Explore Full Report here: https://exactitudeconsultancy.com/reports/73631/plaque-psoriasis-psoriasis-vulgaris-clinical-market
Recent Developments
• Introduction of next-generation IL-17/IL-23 inhibitors with improved dosing intervals.
• New non-steroidal topicals for mild to moderate disease.
• Digital technologies enabling remote monitoring through mobile imaging.
• Combination biologic therapies being evaluated in clinical trials.
• Growing research on personalized medicine and pharmacogenomics in psoriasis.
Expert Quote - Irfan Tamboli (Required)
"Plaque psoriasis management is undergoing a major transformation. With powerful biologics, targeted oral therapies, and digital dermatology, clinicians can now offer more personalized, effective, and long-lasting treatment options to patients worldwide."
- Irfan Tamboli, Business Development Executive, Exactitude Consultancy
Key Market Drivers
• High global disease prevalence & chronic nature of psoriasis
• Increasing biologic and targeted therapy adoption
• Strong pipeline of dermatology drugs
• Rising acceptance of tele-dermatology
• Growing emphasis on early intervention & long-term disease control
Market Forecast & Outlook
Through 2030, the market will expand due to:
• Wider availability of biosimilars lowering treatment costs
• Personalized therapy strategies based on biomarkers
• Greater integration of AI diagnostic tools
• Expansion of biologics to new patient segments
Asia Pacific will be the fastest-growing region, driven by increasing awareness, healthcare modernization, and improved treatment access.
Government & Regulatory Support
• Approval of new biologics & targeted agents by global regulatory bodies
• National screening and awareness programs
• Reimbursement policies supporting biologics in developed markets
• Funding for dermatology research and clinical trials
Conclusion
As therapeutic innovation accelerates and digital dermatology expands, the plaque psoriasis clinical market is entering a new chapter of advanced, patient-centered care. With biologics, targeted oral therapies, and intelligent monitoring systems, the market is positioned for strong growth through 2030.
This report is also available in the following languages : Japanese (尋常性乾癬(尋常性乾癬)の臨床市場), Korean (플라크 건선(Psoriasis Vulgaris) 임상 시장), Chinese (斑块型银屑病(寻常型银屑病)临床市场), French (Marché clinique du psoriasis en plaques (psoriasis vulgaire)), German (Klinischer Markt für Plaque-Psoriasis (Psoriasis vulgaris)), and Italian (Mercato clinico della psoriasi a placche (psoriasi volgare)), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/request-sample/73631
Related Reports
Rhabdomyosarcoma Clinical Market
https://exactitudeconsultancy.com/reports/73635/rhabdomyosarcoma-clinical-market
Sleep Apnea Clinical Market
https://exactitudeconsultancy.com/reports/73637/sleep-apnea-clinical-market
Clostridioides difficile Infections (CDI) Market
https://exactitudeconsultancy.com/reports/73639/clostridioides-difficile-infections-cdi-market
Alzheimers Disease in 68 Market
https://exactitudeconsultancy.com/reports/73641/alzheimers-disease-in-68-market
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Plaque Psoriasis (Psoriasis Vulgaris) Clinical Market Strengthens as Biologics, Targeted Therapies & Digital Dermatology Transform Patient Care here
News-ID: 4293499 • Views: …
More Releases from Exactitude Consultancy
Rhabdomyosarcoma (RMS) Clinical Market Strengthens as Pediatric Oncology Advance …
Rhabdomyosarcoma (RMS)-a rare but aggressive pediatric soft-tissue cancer-is gaining renewed clinical attention as researchers push for better diagnostics, innovative treatment combinations, and targeted therapies. Advancements in precision oncology, supportive care, and early diagnosis are reshaping the global RMS clinical landscape. This press release highlights key market trends, epidemiological insights, therapeutic developments, segmentation analysis, and the evolving strategies improving outcomes for children and adolescents with RMS.
Download Full PDF Sample Copy of…
Inflammatory Bowel Disease (IBD) Clinical Market Expands as Biologics, JAK Inhib …
Inflammatory Bowel Disease (IBD)-including ulcerative colitis (UC) and Crohn's disease (CD)-is a chronic, immune-mediated gastrointestinal condition affecting millions worldwide. As biologics, small-molecule inhibitors, and personalized gastroenterology approaches advance, the IBD clinical market is undergoing a major transformation. This press release explores market growth factors, therapeutic innovations, key segments, and the evolving clinical strategies improving patient outcomes across the globe.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/73633
Market Overview
The Global…
Bronchitis Clinical Market Grows as Respiratory Infections, Air Pollution, and C …
The global bronchitis clinical market is witnessing steady expansion as respiratory infections, air pollution exposure, smoking prevalence, and chronic pulmonary conditions continue to rise worldwide. Healthcare systems are increasingly adopting advanced diagnostics, targeted therapeutics, and integrated respiratory care models. This press release highlights key market trends, epidemiological drivers, segment insights, and the technological innovation shaping modern bronchitis care.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/73629
Market Overview
The Global Bronchitis…
Bio-Pharmaceutical Outsourcing Market Surges as Biologics, Cell & Gene Therapy, …
The global biopharmaceutical industry is rapidly shifting toward outsourced services as pipelines become more complex, timelines compress, and demand for specialized expertise intensifies. From biologics and biosimilars to cell and gene therapies, outsourcing partners-including CROs, CDMOs, and specialized service providers-are becoming indispensable. This press release highlights the major trends, market expansion factors, segmentation insights, and recent developments redefining the biopharmaceutical outsourcing landscape.
Download Full PDF Sample Copy of Market Report @…
More Releases for Psoriasis
Prevalence Of Psoriasis Driving Market Growth: A Key Catalyst Accelerating Psori …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Psoriasis Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
Over the recent years, there has been a robust growth in the size of the psoriasis market. It is estimated to rise from $26.45 billion in 2024 to $28.93 billion in 2025, with a compound annual…
Psoriasis Vulgaris Market
Introduction
Psoriasis vulgaris, also known as plaque psoriasis, is the most common form of psoriasis, accounting for nearly 80-90% of all cases. It is a chronic autoimmune condition marked by red, scaly plaques that can cause significant physical discomfort and emotional distress. Affecting millions worldwide, psoriasis vulgaris is increasingly recognized as both a dermatological and systemic disease due to its association with arthritis, cardiovascular disease, and metabolic syndrome.
The global psoriasis vulgaris…
Major Growth Driver Identified in 2025 Psoriasis Market: Prevalence Of Psoriasis …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Psoriasis Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the size of the psoriasis market has experienced a significant increase. It is projected to escalate from $26.56 billion in 2024 to $29.5 billion in 2025, reflecting a compound annual growth rate (CAGR)…
Prevalence Of Psoriasis Driving Market Growth: Key Factor Driving The Growth In …
The Psoriasis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Psoriasis Market Size During the Forecast Period?
The psoriasis market has seen rapid growth in recent years. It will increase from $26.56 billion in 2024 to $29.5 billion in 2025, at a…
Plaque Psoriasis to Hold 85% Share of Psoriasis Drugs Market through 2031
Psoriasis is a chronic inflammatory skin disease that occurs due to genetic disposition and environmental factors. Psoriasis is a systemic disease associated with psychological, metabolic, arthritic, and cardiovascular comorbidities. On an average, psoriasis affects around 2 - 3% of the population globally.
Plaque psoriasis, being the number one and most common indication, held nearly 85% share of the US$ 11.37 Bn psoriasis drugs market in 2021, with the market estimated to…
Global Psoriasis Market with Focus on Plaque Psoriasis: Outlook to 2020
Psoriasis is a chronic inflammatory skin disease primarily causing scaling and inflammation of skin, characterized by sharply demarcated, scaly, red skin lesions most often on the elbows, knees, scalps, hands and feet. It occurs when the body’s immune system sends out faulty signals that speed up the growth cycle of skin cells. Psoriasis has been majorly classified into Plaque psoriasis, Guttate psoriasis, Inverse psoriasis, Pustular psoriasis and Erytherodermic psoriasis. It…
